Oncogenic and immunological role of EDIL3 in human tumours: From pan-cancer analysis to validation in gastric cancer
Bin Ke(Tianjin Medical University Cancer Institute and Hospital), Ru-Peng Zhang(Tianjin Medical University Cancer Institute and Hospital), Han Liang(The University of Texas MD Anderson Cancer Center), Ning Liu(China Agricultural University), Xuejun Wang(Tianjin Medical University Cancer Institute and Hospital), Peng Jin(Hangzhou Dianzi University)
Cited by 5
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641